The names of more than 100 scientists who will be working to shape a new open-access journal backed by some of the world’s biggest non-governmental research funders have been unveiled.
In total, the board of reviewing editors for the eLife journal number 175 and cover biological areas ranging from stem cells to plants to infectious diseases.
eLife is backed by the US Howard Hughes Medical Institute, the UK Wellcome Trust and Germany’s Max Planck Society. Announced in June last year, its backers hope that the publication will eventually rival Nature and Science as a top-tier journal (see ‘Three major biology funders launch new open access journal, but why exactly?‘).
Randy Schekman, a cell biologist at the University of California, Berkeley, and eLife’s editor-in-chief, said that the calibre of the reviewing editors showed the journal’s commitment to publishing “the world’s most influential and significant research” and told authors to “prepare your papers now”.
The journal promises to open for submission soon, and publishing will be free of charge, “at least for an initial period”.